Osaic Holdings
AQST icon

Osaic Holdings’s Aquestive Therapeutics AQST Stock Holding History

Osaic Holdings’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
48,694
+3,883
+9% +$16.3K ﹤0.01% 4423
2026
Q1 		$186K Sell
44,811
-34,892
-44% -$142K ﹤0.01% 4211
2025
Q4 		$515K Sell
79,703
-66,202
-45% -$413K ﹤0.01% 3310
2025
Q3 		$818K Sell
145,905
-29,636
-17% -$128K ﹤0.01% 2980
2025
Q2 		$581K Sell
175,541
-717
-0.4% -$2.06K ﹤0.01% 3006
2025
Q1 		$511K Buy
176,258
+13,805
+8% +$41.8K ﹤0.01% 2852
2024
Q4 		$578K Buy
162,453
+2,073
+1% +$9.56K ﹤0.01% 2658
2024
Q3 		$799K Buy
160,380
+31,700
+25% +$123K ﹤0.01% 2448
2024
Q2 		$335K Buy
128,680
+42,900
+50% +$143K ﹤0.01% 3106
2024
Q1 		$365K Buy
+85,780
New +$286K ﹤0.01% 3192
2023
Q3 		– Sell
-2,000
Closed -$3.3K – 7391
2023
Q2 		$3.3K Hold
2,000
– – ﹤0.01% 6479
2023
Q1 		$2.28K Hold
2,000
– – ﹤0.01% 6657
2022
Q4 		$2K Hold
2,000
– – ﹤0.01% 6610
2022
Q3 		$2K Hold
2,000
– – ﹤0.01% 6735
2022
Q2 		$1K Hold
2,000
– – ﹤0.01% 7024
2022
Q1 		$5K Hold
2,000
– – ﹤0.01% 6450
2021
Q4 		$8K Hold
2,000
– – ﹤0.01% 6385
2021
Q3 		$9K Hold
2,000
– – ﹤0.01% 6264
2021
Q2 		$8K Buy
+2,000
New +$7.99K ﹤0.01% 6177

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Osaic Holdings's AQST Position: Q2 2026 in Review

Osaic Holdings increased its Aquestive Therapeutics (AQST) stake by 8.7% in Q2 2026, buying an estimated $16.3K and bringing the position to 48,694 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #4423.

Osaic Holdings first reported a position in AQST in Q2 2021 and has held it in 19 quarters since. The position peaked at $818K in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Osaic Holdings held 48,694 shares of Aquestive Therapeutics worth $203K as of Q2 2026.
  • Osaic Holdings bought 3,883 Aquestive Therapeutics shares in Q2 2026, an estimated $16.3K.
  • Aquestive Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4423 holding.
  • Osaic Holdings first reported a position in Aquestive Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Aquestive Therapeutics position peaked at $818K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.